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Abstract
Purpose This study aimed to determine the outcome of
perineal hernia repair with a biological mesh after
abdominoperineal resection (APR).
Method All consecutive patients who underwent perineal
hernia repair with a porcine acellular dermal mesh between
2010 and 2014 were included. Follow-up was performed
by clinical examination and MRI.
Results Fifteen patients underwent perineal hernia repair
after a median of 25 months from APR. Four patients had a
concomitant contaminated perineal defect, for which a
gluteal fasciocutaneous flap was added in three patients.
Wound infection occurred in three patients. After a median
follow-up of 17 months (IQR 12–24), a clinically recurrent
perineal hernia developed in 7 patients (47 %): 6 of 11
patients after a non-cross-linked mesh and 1 of 4 patients
after a cross-linked mesh (p = 0.57). Routine MRI at a
median of 17 months revealed a recurrent perineal hernia
in 7 of 10 evaluable patients, with clinical confirmation of
recurrence in 5 of these 7 patients. No recurrent hernia was
observed in the three patients with combined flap recon-
struction for contaminated perineal defects.
Conclusion A high recurrence rate was observed after
biological mesh repair of a perineal hernia following APR.
Keywords Abdominoperineal resection  Biological
mesh  Perineal hernia  Hernia repair  Dynamic MRI
Introduction
The reported incidence of perineal hernia ranges between 1
and 13 % after abdominoperineal resection (APR) with
primary perineal wound closure for rectal cancer [1]. True
incidences of perineal hernia might even be higher because
of the underreporting of (asymptomatic) perineal hernia. In
addition, literature data may not be representative for
current practice with the increasing use of the extralevator
APR, which has been associated with perineal hernia rate
of up to 26 % [2].
Patients with a symptomatic perineal hernia most often
present with perineal discomfort, pain and urinary dys-
function, and rarely with bowel obstruction. Treatment of
perineal hernia is most often conservative, consisting of
supportive undergarments. When surgical intervention is
indicated, mesh repair is preferred over primary suturing as
a basic treatment principle in hernia surgery [3].
Several types of meshes have been used for perineal
hernia repair, including biological meshes [3]. Biological
meshes are suitable for contaminated fields and are sup-
posed to result in fewer bowel adhesions compared to
synthetic meshes [4, 5]. Because of these characteristics, a
biological mesh may be considered to be of additional
value in the potentially contaminated area of the perineum
and the possibility of small bowel lying on top of it.
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However, current literature on perineal hernia repair with a
biological mesh mainly consists of case reports. Therefore,
the aim of this study was to determine the postoperative
outcome and mid-term follow-up, including magnetic res-
onance imaging (MRI), of a consecutive cohort of perineal
hernia repair using a biological mesh.
Patients and methods
All consecutive patients who underwent a perineal hernia
repair between March 2010 and April 2014 at the Academic
Medical Centre, Amsterdam were included. All perineal
hernia reconstructions were performed or supervised by two
colorectal surgeons (PT and WB) and performed in prone
position using a transperineal approach, except for one
patient who underwent a transabdominal approach.
Transperineal repair started with resection of the redundant
skin and hernia sac. Subsequently, a porcine acellular dermal
mesh was sutured to the sacrococcygeal ligaments dorsally
with interrupted polypropylene 2.0 sutures, resulting in about
2 cm overlap of the mesh to the sacrum. Laterally, the mesh
was fixated to the remnants of the levator muscle with a
small overlap of about 0.5–1.5 cm, and anteriorly the mesh
was folded with about 2 cm overlap against the posterior
vaginal wall or prostate and sutured to the transverse perineal
muscle (Fig. 1). During the study period, we switched from a
cross-linked biological mesh (PermacolTM 10 9 10 cm) to a
non-cross-linked mesh (StratticeTM 6 9 10 cm), related to
institutional uniformity in the use of a biological mesh for all
indications. Thereafter, a 10 French vacuum drain was
placed on top of the mesh and the subcutaneous tissue and
skin were closed. In most cases, the mesh was covered top
side with omentum because an omentoplasty was performed
at the index operation as a routine. When no omentoplasty
was performed at the index operation, a transabdominal
laparoscopic omentoplasty was performed during perineal
hernia repair. If there was insufficient soft tissue to cover the
mesh bottom side, a gluteal fasciocutaneous transposition
flap was used for perineal closure.
Fig. 1 Technique of perineal
hernia repair in prone position
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Postoperatively, the drain was removed after 3–7 days.
Patients were fully mobilized at postoperative day one,
except for those with a gluteal fasciocutaneous flap, who
were mobilized after 3 days and were allowed to sit after
7 days. Follow-up was at least 12 months and consisted of
clinical examination during each visit to the outpatient
clinic. In addition, 10 patients underwent MRI as routine
follow-up between 7 and 41 months from perineal hernia
repair. MRI was performed on 1.5–3 Tesla scanners (Phi-
lips Healthcare, Best, the Netherlands and Siemens Avanto,
Erlangen, Germany) with an axial and/or sagittal, coronal
T2-weighted sequence, and a sagittal and/or coronal
dynamic sequence with Valsalva. The MRI was evaluated
by a gastrointestinal radiologist with extensive experience
in pelvic MRI (JS).
Data extraction
Patient records were retrospectively searched for patient
and treatment characteristics. Baseline data were extracted
on underlying disease, (chemo) radiotherapy, extent of
primary APR, the use of an omentoplasty and the method
of perineal wound closure. Operative reports of perineal
hernia repair were searched for the description of the
operative approach (transperineal, transabdominal), the
type of biological mesh used (cross-linked, non-cross-
linked), and the use of an additional gluteal transposition
flap. Outcome parameters were hospital stay, perineal
wound infection, clinical and radiological recurrence of
perineal hernia, and perineal re-interventions. Clinical
recurrent hernia was defined as a midline swelling in
standing position with absence of the anal cleft and a
palpable pelvic floor defect. A radiological hernia was
defined as descent of small bowel or omentoplasty below
the line between the coccyx and the perineal body (Fig. 3)
or below visible remnants of a mesh.
Statistical analysis
According to the distribution, descriptive data were
reported as median with interquartile range (IQR) or
mean ± standard deviation (SD). Categorical data were
analyzed with the Chi square test or Fisher’s exact test. All
analyses were performed with IBM SPSS statistics, version
20.0.0 (IBM Corp., Armonk, NY, USA).
Results
Patient characteristics
Between March 2010 and April 2014, 15 patients were
operated for a perineal hernia after APR. The patient
characteristics are displayed in Table 1. An extralevator
approach was performed in five of 11 rectal cancer
patients, but in none of them the coccyx was removed. The
perineum was closed primarily in 13 patients, closed with a
biological mesh (PermacolTM) in one patient, and primary
Vacuum Assisted Closure (VAC) was applied in the
remaining patient. A postoperative perineal wound infec-
tion occurred in four of 14 patients with intentionally pri-
mary wound healing, of whom one underwent reoperation
for a presacral abscess and one was treated with VAC
therapy.
A symptomatic perineal hernia developed after a median
of 14 months (IQR 5–34). A total of five patients were
referred from another hospital. Two of them underwent
surgical intervention prior to referral. One patient under-
went laparoscopic biological mesh (PermacolTM) repair of
a perineal hernia 13 months after APR, followed by hys-
terectomy with McCall culdoplasty 17 months later, and
Table 1 Patient, primary treatment and tumor characteristics
Characteristic n = 15
Gender
Male (n, %) 9 (60)
Age
Mean years ± SD 62 ± 11
BMI
Median (IQR) 27 (24–29)
Comorbidity
Diabetes (n, %) 3 (20)
Respiratory (n, %) 0
Cardiac (n, %) 2 (13)
Primary disease
Rectal cancer (n, %) 11 (73)
Anal cancer (n, %) 4 (27)
Radiotherapy
Chemoradiotherapy (n, %) 7 (47)
Short course 5 9 5 Gy (n, %) 6 (40)
Long course without chemotherapy 1 (7)
Type of APR
Conventional APR (n, %) 5 (33)
Extralevator APR (n, %) 5 (33)
Ischio-anal APR (n, %) 4 (27)
Intersphincteric APR (n, %) 1 (7)
Surgery
Laparoscopic approach (n, %) 13 (87)
Omental plasty at time of APR (n, %) 13 (87)
pTNM-stage
Stage I–II (n, %) 9 (60)
Stage III (n, %) 6 (40)
APR abdominoperineal resection, SD standard deviation, IQR
interquartile range
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developed a recurrent perineal hernia. The other patient
underwent hysterectomy and sacrocolpopexy using a pro-
lene mesh (gynemesh) after 18 months because of sexual
dysfunction and feeling of pressure in the perineum and
developed recurrent symptoms with radiological descent of
small bowel beyond the coccyx on imaging.
Perineal hernia repair
Primary perineal hernia repair was performed in 14 patients
after a median of 25 months (IQR 17–55) from primary
APR. The remaining patient was operated upon for recur-
rent perineal hernia 51 months from primary APR and
38 months from first perineal hernia repair. Three female
patients had a non-healing perineal wound together with
perineal herniation, and one male patient was admitted
from the emergency department with a perineal necrosis
and infection. n = 3 primary cross linked mesh recon-
struction at the AMC; n = 11 primary non-cross linked
mesh reconstruction at the AMC; n = 1 referral to the
AMC after cross-linked mesh reconstruction at referring
centre; secondary repair using non-cross linked mesh after
removal of the cross-linked mesh at the AMC. In the
remaining patient, the ‘meshoma’ consisting of a detached
and encapsulated cross-linked biological mesh was
removed (Fig. 2) and a new reconstruction of the pelvic
floor was performed using a non-cross-linked biological
mesh. Details of the perineal hernia and the surgical repair
are summarized in Table 2. The median duration of the
operation without the gluteal fasciocutaneous flap was
97 min (IQR 73–134), which was significantly longer than
231 min (IQR 206–231) when a gluteal fasciocutaneous
flap was performed (p = 0.016). A postoperative perineal
wound infection requiring antibiotic therapy occurred in
three patients, with percutaneous drainage in one of them.
No seroma or fistula formation was observed. The median
postoperative hospital stay was three days (IQR 2–6).
Outcome of perineal hernia reconstruction
The overall clinical recurrence rate of primary perineal
hernia repair using a biological mesh, including the patient
who underwent initial repair at the referring hospital, was
seven of 15 patients (47 %). Recurrent perineal hernia was
diagnosed after a median of 17 months (IQR 12–24). The
median follow-up after hernia repair in patients not having
a recurrent perineal hernia was 20 months (IQR 13–44). A
recurrent perineal hernia occurred in six out of 11 non-
cross-linked biological mesh repairs, and in one out of four
primary repairs using a cross-linked biological mesh
(p = 0.57). None of the three patients treated with an
additional gluteal fasciocutaneous flap had a recurrent
perineal hernia after 13, 13 and 21 months of follow-up.
Routine MRI was performed in 10 patients after a
median of 17 months (IQR 11–30) from perineal hernia
repair (Fig. 3). Five patients did not undergo MRI for the
following reasons; palliative setting with metastatic disease
in two patients, short follow-up (\6 months) in two
patients, and a pacemaker in one patient. Nine out of 10
patients had perineal complaints at the time of MRI, and a
clinical recurrent hernia was diagnosed by physical
examination in five of these patients. The main complaints
consisted of a pressing sensation in seven patients, of
perineal pain in two patients, and dyspareunia in the
remaining patient. A radiological recurrent perineal hernia
was diagnosed on MRI in seven out of the 10 patients. In
one of these seven patients, herniation along both lateral
borders of a cross-linked mesh was visible after 41 months,
but herniation could not be confirmed clinically. In the
other six patients, remnants of a non-cross-linked biologi-
cal mesh could be identified after an interval between 12
and 28 months (Fig. 3b, c), with radiological herniation in
all these patients and clinical recurrence in five patients. In
the three other patients, an intact cross-linked mesh was
visible after 36 months, and an intact non-cross-linked
biological mesh was visible at 7 and 10 months postoper-
atively without signs of recurrent hernia (Fig. 3a). Of the
seven patients with a recurrent hernia, four patients
underwent a redo perineal hernia reconstruction with a
Fig. 2 Explant of a cross-linked biological mesh
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synthetic mesh (Table 2). The sutures of the previous
reconstruction were not migrated, and the initial non-cross-
linked biological mesh could not be identified anymore.
Discussion
To our knowledge, we report the largest cohort of patients
who underwent a biological mesh reconstruction of a per-
ineal hernia. A relatively high recurrence rate of 47 % was
found, which may even become higher with extended fol-
low-up. Current literature on perineal hernia repair after
APR is limited. A systematic review of the literature iden-
tified 39 relevant papers between 1939 and 2011, describing
only 76 patients who underwent surgical repair of a perineal
hernia [3]. A biological mesh was used in only five of those
patients, reported by three different authors [6–8]. Only one
case report on biological mesh repair has been published
thereafter [9]. These case reports are mainly focused on
surgical technique, have an inherent risk of publication bias
with often reporting successes, and follow-up is insufficient
to draw any conclusion on long-term outcome.
The 47 % recurrence rate found in our study is consid-
erably higher than a recently reported 5 % recurrence rate
after transperineal synthetic mesh reconstruction of
uncomplicated perineal hernia repair in 21 patients with a
median follow-up of 24 months [10]. Reported mesh size
in case reports using synthetic meshes is also larger than
the size of the non-cross-linked biological mesh that we
used, with a mesh width ranging from 8 to 18 cm
[9, 11–15]. Therefore, we recently changed our approach to
synthetic mesh repair using a larger size (15 9 15 cm) for
primary and recurrent perineal hernias in the absence of
contamination, combined with an omentoplasty if not
Table 2 Perineal hernia repair using a biological mesh with subsequent outcome (n = 15)
Number Status Perineal hernia repair Follow-up
6 Uncomplicated perineal healing, primary
perineal hernia
Transperineal StratticeTM n = 2 no recurrent hernia 13/18 m
n = 2 recurrent hernia 14/24 m, no further
intervention
n = 1 recurrent hernia 17 m, prolene mesh repair
22 m, recurrent hernia 33 m
n = 1 recurrent hernia 9 m, prolene mesh repair
10 m, second recurrent hernia 14 m, prolene mesh
repair 16 m, no recurrent hernia 25 m
2 Uncomplicated perineal healing, primary
perineal hernia
Transperineal PermacolTM n = 1 no recurrent hernia, exenteration because of
recurrent rectal cancer 24 m
n = 1 laparoscopic prolene mesh fixation of
biological mesh anteriorly 10 m, no recurrent
hernia 46 m (radiological recurrence)
1 Omental prolapse with perineal necrosis Transperineal StratticeTM 44 m Recurrent hernia 28 m, prolene mesh repair 29 m,
no recurrent hernia 39 m
1 Primary PermacolTM at time of APR,
primary perineal hernia
Transperineal StratticeTM 17 m Recurrent hernia 12 m, no further intervention
1 Surgical abscess drainage with secondary
healing, perineal defect with uterine
prolapse
Transperineal repair posterior
vaginal wall ? StratticeTM ?
bilateral VY gluteal flap 94 m
No recurrent hernia 21 m
1 Primary VAC therapy with secondary
healing, omental prolapse with chronic
wound
Transperineal StratticeTM ?
unilateral VY gluteal flap 8 m
No recurrent hernia 13 m, metastatic disease
1 Secondary VAC therapy, omental prolapse
with chronic wound
Transperineal repair posterior
vaginal wall ? StratticeTM ?
unilateral SGAP flap 17 m
No recurrent hernia 13 m, metastatic disease
1 Hysterectomy ? sacrocolpopexy for sexual




omental plasty ? bladder
interposition 53 m
No recurrent hernia 36 m
1 Laparoscopic perineal hernia repair with
PermacolTM 13 m,






No recurrent hernia 14 m
No. number of patients, VAC vacuum assisted wound closure, APR abdominoperineal resection, SGAP superior gluteal artery fasciocutaneous
perforator flap, (x) m = time interval in months from primary APR or perineal hernia repair
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already present. We still prefer the transperineal approach,
but others effectively use a (laparoscopic) trans-abdominal
route of mesh placement [16, 17]. Reasons for using a
transperineal approach are the easier ventral fixation to the
transverse perineal muscles, the better visualization of the
neurovascular bundles along the prostate that should not be
included in the stitches to prevent postoperative pain, and
the lesser costs compared to a laparoscopic approach with
the use of disposables.
The 93 % radiotherapy rate may have contributed to the
high failure rate. A biological mesh provides a scaffold for
ingrowth by host tissue, leading to integration of the mesh
[18]. Radiotherapy disrupts cellular cytokine reactions and
reduces nitric oxide and metalloproteinase [19, 20]. As a
result, inadequate soft tissue regeneration and disorganized
deposition of collagen occur [19, 21]. The amount of cross
linking might be another explanation for the high recur-
rence rate, because a non-cross-linked biological mesh was
used in the majority of patients [22]. Cross-links are
covalent bonds between the collagen and are supposed to
resist collagen degradation by host or bacterial collagenase
[23, 24]. Thereby, cross linking increases tensile strength
which is supposed to result in a lower rate of recurrent
hernia compared to non-cross-linked meshes, especially in
a contaminated field. On the other hand, cross linking may
restrict early cellular infiltration and may elicit an unin-
tended inflammatory response, which could lead to fibrosis
and could limit tissue remodeling [25, 26]. Encapsulation
of a cross-linked mesh similar to a synthetic mesh was
observed in one of our patients. Furthermore, fistula for-
mation after a cross-linked biological mesh repair of a
perineal hernia has been described [27]. Currently available
literature does not allow for a definitive answer on the
preferred type of biological mesh.
If no omentoplasty has been performed at time of pri-
mary APR, small bowel will lie on top of the mesh fol-
lowing perineal hernia repair. Direct contact of bowel loops
to a mesh might lead to adhesion or fistula formation.
Besides small bowel descent, an omentoplasty also mini-
mizes dorsal displacement of the internal genital organs and
bladder, which is associated with sexual and bladder dys-
function, respectively. This is the reason why we consider
adding an omentoplasty to the hernia repair if not done so
primarily to restore pelvic anatomy as much as possible.
In this study, hernia repair was combined with a gluteal
fasciocutaneous flap (VY or SGAP) to fill and close a
chronic perineal defect in three patients. A gluteal flap does
probably not add any strength to the pelvic floor recon-
struction [28]. However, it is important to adequately cover
the mesh with well-vascularized subcutaneous tissue to
prevent seroma and abscess formation below the mesh, and
to close the perineal skin without tension. Loss of perineal
tissue related to extended primary resection or infectious
complications requiring debridement may require autolo-
gous tissue flap reconstruction. All three patients with
combined biological mesh and flap reconstruction were
still without signs of recurrent hernia at last follow-up.
Probably, the use of a biological mesh for pelvic floor
reconstruction should be restricted to such patients with
contaminated perineal defects.
Adequate follow-up to determine success of hernia
repair is essential and routine imaging may be the most
objective measure. However, imaging might overestimate
the clinically relevant recurrence rate as shown by the
present data. MRI to evaluate perineal hernia repair using a
biological mesh has first been described by Kavanagh et al.
in a single case [29]. We performed MRI during follow-up
to assess the basis for perineal complaints, with specific
focus on mesh ingrowth and remodeling and potential
mechanisms of technical failure. Because often little rem-
nants of the mesh could be identified anymore on MRI,
biological mesh degradation with inadequate tissue
remodeling seemed to be the main reason for failure, which
was supported by the findings during redo surgery.
Fig. 3 MRI images of two patients after perineal hernia repair.
a Sagittal plane, T2-weighted sequence, sufficient hernia repair with
visible biological mesh between the coccyx and the perineal body. b,
c Transverse and sagittal images, T2-weighted sequence, of a patient
with a recurrent hernia, revealing remnants of the biological mesh
along the posterior and right lateral borders of the perineal defect.
Recurrent perineal hernia is defined as descent of small bowel or
omentoplasty below the line drawn on a sagittal imaging. Arrow
remnants of the biological mesh
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However, shrinkage of the biological mesh or the size of
the mesh used might have contributed to the high recur-
rence rate as well [30]. With the standard available size of
the non-cross-linked mesh for this indication (6 9 10 cm),
there is only a few centimeters overlap ventrally and dor-
sally with almost no overlap towards the pelvic side walls.
Furthermore, a transperineal approach does not allow for
additional fixation of the edges of the overlapping mesh in
addition to the sutures along the defect. This might be
essential, because the mesh does often not smoothly follow
the funnel shape of the pelvis, which limits contact of the
mesh to surrounding tissues and may affect ingrowth.
Limitations of this study are its retrospective design and
the limited number of patients included. Failure may be
associated with restricted experience, because of the rarity
of this problem. However, our group also conducted a
multicenter randomized controlled trial on pelvic floor
reconstruction using a biological mesh following extrale-
vator APR during the study period, which contributed to
our expertise in this field [31]. Also, follow-up is still
relatively short, and imaging was not performed at stan-
dardized follow-up intervals.
Despite these limitations, this study shows that perineal
hernia reconstruction with a 6 9 10 cm non-cross-linked
biological mesh via a transperineal approach results in a
high recurrence rate in patients who underwent APR for
cancer. Our little experience with cross-linked biological
mesh does not allow for any conclusion. A biological mesh
may not be the first choice implant for perineal hernia
repair in the absence of contamination and the presence of
an omentoplasty.
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